(Nasdaq:RGNX), a leading biotechnology company in gene therapy, today announced the closing of its initial public offering of 7,, shares of common stock. (Nasdaq:RGNX), a leading biotechnology company in gene therapy, today announced the closing of its initial public offering of 7,, shares of common stock. Get the latest Regenxbio Inc (RGNX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading. On average, Wall Street analysts predict that Regenxbio's share price could reach $ by Sep 4, The average Regenxbio stock price prediction forecasts. Get the latest updates on REGENXBIO Inc. Common Stock (RGNX) after hours trades, after hours share volumes, and more. Make informed investments with Nasdaq.
A high-level overview of REGENXBIO Inc. (RGNX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment. ("REGENXBIO"), a leading biotechnology company in gene therapy, today announced the pricing of its initial public offering of 6,, shares of its common. RGNX | Complete REGENXBIO Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated. The latest REGENXBIO stock prices, stock quotes, news, and RGNX history to help you invest and trade smarter. REGENXBIO is a leading clinical-stage biotechnology company seeking to © REGENXBIO Inc. • "NAV®" is a registered trademark of REGENXBIO Inc. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United. Regenxbio Inc ; Feb, Resumed, Raymond James, Outperform, $45 ; Nov, Initiated, Stifel, Buy, $ RGNX Regenxbio Inc. 2, $ $ (%). Today. Watchers, 2, Wk Low, $ Wk High, $ Market Cap, $M. Volume, , Stock analysis for REGENXBIO Inc (RGNX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
8, /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the pricing of an underwritten public offering of 4,, shares of its common stock. REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Discover real-time REGENXBIO Inc. Common Stock (RGNX) stock prices, quotes, historical data, news, and Insights for informed trading and investment. REGENXBIO (RGNX) Valuation: RGNX Stock Looks Appropriately Priced With $37 Price Estimate Regenxbio (RGNX) Soars %: Is Further Upside Left in the Stock? Regenxbio (RGNX) saw its shares surge in the last session with trading volume being higher. View the latest REGENXBIO Inc. (RGNX) stock price, news, historical charts, analyst ratings and financial information from WSJ. REGENXBIO Inc. ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. View REGENXBIO, Inc. RGNX stock quote prices, financial information, real-time forecasts, and company news from CNN. shares of its common stock at the price of $ per share before underwriting discounts and commissions. The gross proceeds to REGENXBIO from the offering.
Regenxbio Inc ; Previous Close: ; Open: ; Volume: , ; 3 Month Average Trading Volume: ; Shares Out (Mil): Key Stats · Market CapM · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change REGENXBIO (RGNX) · After Hours PM ET 08/08/ $ %. Previous Close · $ · ; % · Volume: , · Volume % Chg: 44% · Get a. RGNX - REGENXBIO Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS). Regenxbio · Market Cap · P/E Ratio (ttm) · Forward P/E · Diluted EPS (ttm) · Dividends Per Share · Dividend Yield · Ex-Dividend Date.
Regenxbio - Learn How I Turned $15,253 Into $1,613,442 Trading Biotech Stocks
REGENXBIO Announces Successful Pre-BLA Meeting with FDA to Support Accelerated Approval Pathway for RGX for the Treatment of MPS II PR Newswire ROCKVILLE. REGENXBIO Inc. (applsupport.online): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock REGENXBIO Inc. | Nasdaq: RGNX | Nasdaq. RegenXBio (RGNX) has a Smart Score of 5 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.
Cost Of Removing Raccoons From Attic | Learn To Be A Computer Programmer